Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
102.50 USD | +4.34% | +1.31% | +20.11% |
Dec. 13 | Samsung, SK Hynix Await Subsidy Approval as Micron Secures $6.1 Billion CHIPS Act Funding | MT |
Dec. 12 | Europe eases with Swiss surprise as Nasdaq clocks 20k | RE |
Fiscal Period: August | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 21.44B | 27.7B | 30.76B | 15.54B | 25.11B | |||||
Total Revenues | 21.44B | 27.7B | 30.76B | 15.54B | 25.11B | |||||
Cost of Goods Sold, Total | 14.88B | 17.23B | 16.86B | 16.96B | 19.5B | |||||
Gross Profit | 6.55B | 10.47B | 13.9B | -1.42B | 5.61B | |||||
Selling General & Admin Expenses, Total | 881M | 894M | 1.07B | 920M | 1.13B | |||||
Stock-Based Compensation (IS) | - | - | - | - | - | |||||
R&D Expenses | 2.6B | 2.66B | 3.12B | 3.11B | 3.43B | |||||
Other Operating Expenses | 11M | 119M | 7M | 9M | -192M | |||||
Other Operating Expenses, Total | 3.49B | 3.68B | 4.19B | 4.04B | 4.37B | |||||
Operating Income | 3.06B | 6.8B | 9.71B | -5.46B | 1.25B | |||||
Interest Expense, Total | -194M | -183M | -189M | -388M | -562M | |||||
Interest And Investment Income | 114M | 37M | 96M | 468M | 529M | |||||
Net Interest Expenses | -80M | -146M | -93M | 80M | -33M | |||||
Income (Loss) On Equity Invest. | 7M | 37M | 4M | 2M | -11M | |||||
Currency Exchange Gains (Loss) | -8M | - | - | - | - | |||||
Other Non Operating Income (Expenses) | 28M | - | 19M | 15M | 1M | |||||
EBT, Excl. Unusual Items | 3.01B | 6.69B | 9.64B | -5.36B | 1.2B | |||||
Restructuring Charges | 11M | -537M | -48M | -171M | -1M | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Impairment of Goodwill | - | - | - | -101M | - | |||||
Gain (Loss) On Sale Of Investments | - | 82M | 26M | -8M | -32M | |||||
Gain (Loss) On Sale Of Assets | 3M | 24M | 41M | 54M | 59M | |||||
Asset Writedown | -71M | - | - | - | - | |||||
Legal Settlements | - | - | - | -68M | - | |||||
Other Unusual Items | 40M | -1M | -83M | - | - | |||||
EBT, Incl. Unusual Items | 2.99B | 6.26B | 9.58B | -5.66B | 1.23B | |||||
Income Tax Expense | 280M | 394M | 888M | 177M | 451M | |||||
Earnings From Continuing Operations | 2.71B | 5.86B | 8.69B | -5.83B | 778M | |||||
Net Income to Company | 2.71B | 5.86B | 8.69B | -5.83B | 778M | |||||
Minority Interest | -23M | - | - | - | - | |||||
Net Income - (IS) | 2.69B | 5.86B | 8.69B | -5.83B | 778M | |||||
Net Income to Common Incl Extra Items | 2.69B | 5.86B | 8.69B | -5.83B | 778M | |||||
Net Income to Common Excl. Extra Items | 2.69B | 5.86B | 8.69B | -5.83B | 778M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 2.42 | 5.23 | 7.81 | -5.34 | 0.7 | |||||
Basic EPS - Continuing Operations | 2.42 | 5.23 | 7.81 | -5.34 | 0.7 | |||||
Basic Weighted Average Shares Outstanding | 1.11B | 1.12B | 1.11B | 1.09B | 1.1B | |||||
Net EPS - Diluted | 2.37 | 5.14 | 7.75 | -5.34 | 0.7 | |||||
Diluted EPS - Continuing Operations | 2.37 | 5.14 | 7.75 | -5.34 | 0.7 | |||||
Diluted Weighted Average Shares Outstanding | 1.13B | 1.14B | 1.12B | 1.09B | 1.12B | |||||
Normalized Basic EPS | 1.67 | 3.73 | 5.42 | -3.07 | 0.68 | |||||
Normalized Diluted EPS | 1.64 | 3.66 | 5.37 | -3.07 | 0.67 | |||||
Dividend Per Share | - | 0.1 | 0.43 | 0.46 | 0.46 | |||||
Payout Ratio | - | - | 5.31 | -8.64 | 65.94 | |||||
American Depositary Receipts Ratio (ADR) | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | |||||
Supplemental Items | ||||||||||
EBITDA | 8.71B | 13.01B | 16.82B | 2.21B | 8.94B | |||||
EBITA | 3.06B | 6.8B | 9.71B | -5.46B | 1.25B | |||||
EBIT | 3.06B | 6.8B | 9.71B | -5.46B | 1.25B | |||||
EBITDAR | 8.81B | 13.12B | 16.95B | 2.35B | 9.08B | |||||
Effective Tax Rate - (Ratio) | 9.36 | 6.3 | 9.27 | -3.13 | 36.7 | |||||
Current Domestic Taxes | 22M | 43M | 66M | 6M | 83M | |||||
Current Foreign Taxes | 148M | 370M | 528M | 178M | 333M | |||||
Total Current Taxes | 170M | 413M | 594M | 184M | 416M | |||||
Deferred Domestic Taxes | -62M | -19M | 391M | 84M | -18M | |||||
Deferred Foreign Taxes | 172M | - | -97M | -91M | 53M | |||||
Total Deferred Taxes | 110M | -19M | 294M | -7M | 35M | |||||
Normalized Net Income | 1.86B | 4.18B | 6.02B | -3.35B | 752M | |||||
Interest Capitalized | 77M | 66M | 77M | 208M | 225M | |||||
Interest on Long-Term Debt | 107M | 86M | 101M | 232M | 295M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 2.6B | 2.66B | 3.12B | 3.11B | 3.43B | |||||
Net Rental Expense, Total | 102M | 108M | 125M | 137M | 140M | |||||
Imputed Operating Lease Interest Expense | 33.81M | 29.54M | 35.68M | 60.55M | 62.79M | |||||
Imputed Operating Lease Depreciation | 68.19M | 78.46M | 89.32M | 76.45M | 77.21M | |||||
Stock-Based Comp., COGS (Total) | 139M | 186M | 193M | 201M | 312M | |||||
Stock-Based Comp., R&D Exp. (Total) | 86M | 110M | 175M | 226M | 296M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 103M | 99M | 133M | 137M | 213M | |||||
Stock-Based Comp., Other (Total) | - | - | - | 32M | 12M | |||||
Total Stock-Based Compensation | 328M | 395M | 501M | 596M | 833M |